CMG Pharmaceutical Company Description

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea.

It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis.

CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment.

The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013.

CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.

CMG Pharmaceutical Co., Ltd.

Country	South Korea
Founded	2001
Industry	Pharmaceutical Preparations
Employees	277
CEO	Joohyung Lee

Contact Details

Address: Cheongdam-dong 18-20, #B01 Seoul, 135-949 South Korea
Website	cmgpharma.co.kr

Stock Details

Ticker Symbol	058820
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2834

Key Executives

Name	Position
Joohyung Lee	Chief Executive Officer